Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats

被引:106
作者
Blanco-Rivero, J
Cachofeiro, V
Lahera, V
Aras-Lopez, R
Márquez-Rodas, I
Salaices, M
Xavier, FE
Ferrer, M
Balfagón, G
机构
[1] Univ Autonoma Madrid, Fac Med, Dept Fisiol, E-28029 Madrid, Spain
[2] Univ Autonoma Madrid, Fac Med, Dept Farmacol, E-28029 Madrid, Spain
[3] Univ Complutense, Fac Med, Dept Fisiol, E-28040 Madrid, Spain
[4] Univ Fed Espirito Santo, Programa Posgrad Ciencias Fisiol, Vitoria, ES, Brazil
关键词
aldosterone; endothelium; prostacyclin; normotension; hypertension;
D O I
10.1161/01.HYP.0000171479.36880.17
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The aim of the present study was to analyze the possible involvement of vasoconstrictors prostanoids on the reduced endothelium-dependent relaxations produced by chronic administration of aldosterone in Wistar Kyoto rats ( WKY) and spontaneously hypertensive rats ( SHR). For this purpose, acetylcholine ( ACh) relaxations in aortic segments from both strains were analyzed in absence and presence of the cyclooxygenase-1 ( COX-1) and COX-2 inhibitor indomethacin, the specific COX-2 inhibitor NS-398, the TP receptor antagonist ( SQ 29 548), the thromboxane A(2) ( TXA(2)) synthase inhibitor furegrelate, and the prostacyclin ( PGI(2)) synthesis inhibitor tranylcypromine ( TCP). In addition, COX-2 protein expression was studied by Western blot analysis. Release of prostaglandin E-2 ( PGE(2)) and the metabolites of PGF(2 alpha), TXA(2), and PGI(2), 13,14-dihydro-15-keto PGF(2a), TXB2, and 6-keto-PGF(1 alpha), respectively, were measured. Treatment with aldosterone did not modify blood pressure levels in any strain. However, aldosterone markedly reduced ( P < 0.05) ACh-induced relaxations in segments from both strains in a similar extent. Indomethacin, NS-398, SQ 29 548, and TCP enhanced ( P < 0.05) ACh relaxations in both strains treated with aldosterone. Aortic COX-2 protein expression was higher in both strains of rats treated with aldosterone. In normotensive animals, aldosterone increases the ACh-stimulated aortic production of 13,14-dihydro-15-keto PGF(2a), PGE(2), and 6-keto-PGF(1 alpha) ( P < 0.05). In SHR, ACh only increased the 6-keto-PGF(1 alpha) production ( P < 0.05). It could be concluded that chronic treatment with aldosterone was able to produce endothelial dysfunction through COX-2 activation in normotensive and hypertensive conditions. PGI(2) seems to be the main factor accounting for endothelial dysfunction in hypertensive rats, whereas other prostanoids besides PGI(2) appear to be involved in endothelial dysfunction under normotensive conditions.
引用
收藏
页码:107 / 112
页数:6
相关论文
共 40 条
[11]   Non-genomic actions of aldosterone: role in hypertension [J].
Funder, JW .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2001, 10 (02) :227-230
[12]   Renal potassium transport: mechanisms and regulation [J].
Giebisch, G .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1998, 274 (05) :F817-F833
[13]   Renal tubule potassium channels: function, regulation and structure [J].
Giebisch, G ;
Wang, W .
ACTA PHYSIOLOGICA SCANDINAVICA, 2000, 170 (02) :153-173
[14]   ALDOSTERONE INHIBITS NITRIC-OXIDE SYNTHESIS IN RAT VASCULAR SMOOTH-MUSCLE CELLS INDUCED BY INTERLEUKIN-1-BETA [J].
IKEDA, U ;
KANBE, T ;
NAKAYAMA, I ;
KAWAHARA, Y ;
YOKOYAMA, M ;
SHIMADA, K .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 290 (02) :69-73
[15]   DIFFERENT MECHANISMS OF ENDOTHELIAL DYSFUNCTION WITH AGING AND HYPERTENSION IN RAT AORTA [J].
KUNG, CF ;
LUSCHER, TF .
HYPERTENSION, 1995, 25 (02) :194-200
[16]   PROSTACYCLIN-INDUCED CONTRACTION OF ISOLATED AORTIC STRIPS FROM NORMAL AND SPONTANEOUSLY HYPERTENSIVE RATS (SHR) [J].
LEVY, JV .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1980, 19 (04) :517-525
[17]   The neurohormonal natural history of essential hypertension: towards primary or tertiary aldosteronism? [J].
Lim, PO ;
Struthers, AD ;
MacDonald, TM .
JOURNAL OF HYPERTENSION, 2002, 20 (01) :11-15
[18]   Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids [J].
Matz, RL ;
de Sotomayor, MA ;
Schott, C ;
Stoclet, JC ;
Andriantsitohaina, R .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (02) :303-311
[19]   Endothelial dysfunction: From physiology to therapy [J].
Mombouli, JV ;
Vanhoutte, PM .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1999, 31 (01) :61-74
[20]   Prostanoid receptors: Structures, properties, and functions [J].
Narumiya, S ;
Sugimoto, Y ;
Ushikubi, F .
PHYSIOLOGICAL REVIEWS, 1999, 79 (04) :1193-1226